Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Szokodi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|November 13, 2019
[A short and pragmatic guide through diagnostics and therapies of chronic inflammatory bowel diseases]Thomas Ochsenkühn, Daniel Szokodi, Cornelia Tillack
United European Gastroenterology Journal|March 28, 2020
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitisThomas Ochsenkühn, Cornelia Tillack, Daniel Szokodi, et al.
MMW Fortschritte Der Medizin|October 31, 2025
[Chronic inflammatory bowel diseases in general practice]Thomas Ochsenkühn, Cornelia Tillack-Schreiber, Daniel Szokodi, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic areaConstanze H Waggershauser, Cornelia Tillack-Schreiber, Christine Berchtold-Benchieb, et al.
Chinese Medical Journal|July 23, 2002
Expression of cyclin genes in human gastric cancer and in first degree relativesJun Yu, Stephan Miehlke, Matthias P A Ebert, et al.
Plos One|January 18, 2024
Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban centerFabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, et al.
Canadian Journal of Gastroenterology & Hepatology|September 5, 2022
Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD PatientsConstanze Heike Waggershauser, Cornelia Tillack-Schreiber, Paul Weyh, et al.
Digestive Diseases and Sciences|June 18, 2002
Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relativesStephan Miehlke, Jun Yu, Matthias Ebert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|November 13, 2019
[A short and pragmatic guide through diagnostics and therapies of chronic inflammatory bowel diseases]Thomas Ochsenkühn, Daniel Szokodi, Cornelia Tillack
United European Gastroenterology Journal|March 28, 2020
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitisThomas Ochsenkühn, Cornelia Tillack, Daniel Szokodi, et al.
MMW Fortschritte Der Medizin|October 31, 2025
[Chronic inflammatory bowel diseases in general practice]Thomas Ochsenkühn, Cornelia Tillack-Schreiber, Daniel Szokodi, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic areaConstanze H Waggershauser, Cornelia Tillack-Schreiber, Christine Berchtold-Benchieb, et al.
Chinese Medical Journal|July 23, 2002
Expression of cyclin genes in human gastric cancer and in first degree relativesJun Yu, Stephan Miehlke, Matthias P A Ebert, et al.
Plos One|January 18, 2024
Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban centerFabian Schnitzler, Cornelia Tillack-Schreiber, Daniel Szokodi, et al.
Canadian Journal of Gastroenterology & Hepatology|September 5, 2022
Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD PatientsConstanze Heike Waggershauser, Cornelia Tillack-Schreiber, Paul Weyh, et al.
Digestive Diseases and Sciences|June 18, 2002
Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relativesStephan Miehlke, Jun Yu, Matthias Ebert, et al.
Pageof 1